Exact Sciences Corp (NASDAQ:EXAS)
During the Trading Day
| 12.90 |  +0.07 / +0.55% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 12.90 |  0.00 / 0.00% |
Volume: 6.7K |
Latest EXAS News | Press Releases
| Exact Sciences Floats New Stock Issue Jun 18 / MotleyFool.com | Biotech Stock Mailbag: Exact Sciences, Questcor, Biotech M&A, Celsion Jun 14 / TheStreet.com |
| UPDATE: Exact Sciences Announces Proposed Public Offering of Common Stock Jun 17 / Benzinga |
Today’s Trading
| Previous close | 12.83 |
| Today’s open | 12.87 |
| Day’s range | 12.60 - 13.16 |
| Volume | 1,317,063 |
| Average volume (3 months) | 1,637,102 |
| Market cap | $822.3M |
| Dividend yield | -- |
Data as of 4:00pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | -60.00% |
| Earnings growth (this year) | +13.54% |
| Earnings growth (next 5 years) | +65.00% |
| Revenue growth (last year) | -0.46% |
| P/E ratio | NM |
| Price/Sales | 152.00 |
| Price/Book | 8.32 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABMDAbiomed Inc | +0.07 | +0.32% |
| TRNXTornier NV | -0.21 | -1.23% |
| LMNXLuminex Corp | -0.39 | -1.88% |
| OMCLOmnicell Inc | -0.06 | -0.31% |
Data as of 4:00pm ET, 06/19/2013
Financials
| Next reporting date | July 29, 2013 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $4.1M |
| Annual profit (last year) | -$52.4M |
| Net profit margin | -1,264.99% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Kevin T. Conroy |
Chief Operating Officer, CFO, Secretary & SVP Maneesh K. Arora, MBA |
Corporate headquarters Madison, Wisconsin |
Forecasts
